K. Quillen M.D. M.P.H.
Karen Quillen
Degree(s) – M.D., M.P.H.
Academic Title –
- Associate Professor, Pathology and Laboratory Medicine
- Associate Professor, Medicine
Education/Training -
- A.B. Harvard College
- M.D. Queen’s University , Canada
- M.P.H. Boston University
- Residency in Medicine, Brigham & Women’s Hospital
- Fellowship in Hematology/Transfusion Medicine, New England Medical Center
Research Interests –
- Hematopoietic stem cell transplantation for AL amyloidosis
- Transfusion reactions
- Rational transfusion management of acquired coagulopathies
Recent Publications -
-
Quillen K. Hypotensive transfusion reactions in patients taking angiotensin-converting-enzyme inhibitors. New Engl J Med 2000; 343:1422-3.
-
Sanchorawala V, Wright D, Seldin D, Falk R, Finn K, Dember L, Berk J, Quillen K, Anderson J, Comenzo R, Skinner M. High-dose intravenous melphalan and autologous stem cell transplantation as initial therapy or following two cycles of oral chemotherapy for the treatment of AL amyloidosis: results of a prospective randomized trial. Bone Marrow Transplant 2004; 33:381-388.
-
Quillen K, Murphy K. Quality improvement to decrease specimen mislabeling in transfusion medicine. Arch Pathol Lab Med 2006;130:1196-1198.
-
Bauza G, Hirsch E, Burke P, Quillen K. Low-dose recombinant activated factor VII in massively transfused trauma patients with coagulopathy. Transfusion 2007; 47:749-751.
-
Divinagracia TV, Emhoff TA, Agarwal SK, Burke PA, Quillen K, Hirsch EF. Perioperative complications in a patient with sickle cell disease following penetrating trauma. Injury Extra 2008; 39:56-58.
-
Quillen K, Hu E, Lane C, Pelton S, Bateman S. Prevalence of ceftriaxone and cefotaxime-induced red blood cell antibodies in pediatric HIV and sickle cell patients. Pediatric Infect Dis J 2008; 27: 357-8.
Contact Information
- Telephone – 617-638-7828
- Email – kq@bu.edu
